气体交换对肺动脉高压患者运动训练反应的影响。
The impact of gas transfer on responses to exercise training in patients with pulmonary hypertension.
作者信息
McCormack Ciara, Kehoe Brona, McCullagh Brian, Gaine Sean, Moyna Niall M, Quadery Syed Rehan
机构信息
Department of Sport Science and Nutrition Maynooth University Maynooth Kildare Ireland.
National Pulmonary Hypertension Unit Mater Misericordiae University Hospital Dublin Ireland.
出版信息
Pulm Circ. 2024 Sep 25;14(3):e12438. doi: 10.1002/pul2.12438. eCollection 2024 Jul.
Abstract
Exercise training is recommended for pulmonary hypertension (PH). Post hoc analysis of the PH and Home-Based (PHAHB) trial stratified patients into two groups based on median diffusing capacity of the lungs for carbon monoxide (DLCO). Patients with higher DLCO had a greater improvement in physical activity performance in response to exercise training, compared to those with lower DLCO. DLCO may be an important consideration in prescribing exercise in PH.
摘要
推荐对肺动脉高压（PH）患者进行运动训练。对肺动脉高压与居家治疗（PHAHB）试验进行事后分析，根据肺一氧化碳弥散量（DLCO）的中位数将患者分为两组。与DLCO较低的患者相比，DLCO较高的患者在接受运动训练后体力活动表现有更大改善。在为PH患者开运动处方时，DLCO可能是一个重要的考虑因素。
相似文献
1
The impact of gas transfer on responses to exercise training in patients with pulmonary hypertension.气体交换对肺动脉高压患者运动训练反应的影响。
Pulm Circ. 2024 Sep 25;14(3):e12438. doi: 10.1002/pul2.12438. eCollection 2024 Jul.
2
Low resting diffusion capacity, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者静息时弥散功能降低、呼吸困难和运动耐量下降。
J Appl Physiol (1985). 2019 Oct 1;127(4):1107-1116. doi: 10.1152/japplphysiol.00341.2019. Epub 2019 Aug 1.
3
Membrane and capillary blood components of diffusion capacity of the lung for carbon monoxide in pulmonary sarcoidosis: relation to exercise gas exchange.肺结节病中肺一氧化碳弥散能力的膜性和毛细血管血液成分：与运动气体交换的关系
Chest. 2004 Jun;125(6):2061-8. doi: 10.1378/chest.125.6.2061.
4
Simultaneous Measurement of Lung Diffusing Capacity and Pulmonary Hemodynamics Reveals Exertional Alveolar-Capillary Dysfunction in Heart Failure With Preserved Ejection Fraction.同时测量肺弥散能力和肺血流动力学揭示射血分数保留的心力衰竭患者运动时肺泡-毛细血管功能障碍。
J Am Heart Assoc. 2021 Aug 17;10(16):e019950. doi: 10.1161/JAHA.120.019950. Epub 2021 Aug 7.
5
Lower DLco% identifies exercise pulmonary hypertension in patients with parenchymal lung disease referred for dyspnea.较低的一氧化碳弥散量百分比（DLco%）可识别因呼吸困难而转诊的实质性肺疾病患者中的运动性肺动脉高压。
Pulm Circ. 2020 Feb 19;10(1):2045894019891912. doi: 10.1177/2045894019891912. eCollection 2020 Jan-Mar.
6
The effect of heat on lung diffusing capacity for carbon monoxide (DLCO) during cycling exercise.骑行运动期间热量对肺一氧化碳弥散量（DLCO）的影响。
Eur J Appl Physiol. 2024 Feb;124(2):469-477. doi: 10.1007/s00421-023-05280-7. Epub 2023 Aug 7.
7
Survival in pulmonary hypertension due to chronic lung disease: Influence of low diffusion capacity of the lungs for carbon monoxide.慢性肺部疾病导致肺动脉高压患者的生存率：一氧化碳肺弥散量降低的影响。
J Heart Lung Transplant. 2019 Feb;38(2):145-155. doi: 10.1016/j.healun.2018.09.011. Epub 2018 Sep 14.
8
Prognostic and pathophysiological marker for patients with chronic thromboembolic pulmonary hypertension: Usefulness of diffusing capacity for carbon monoxide at diagnosis.慢性血栓栓塞性肺动脉高压患者的预后和病理生理标志物：诊断时一氧化碳弥散能力的效用
Respirology. 2017 Jan;22(1):179-186. doi: 10.1111/resp.12883. Epub 2016 Sep 11.
9
Does reduced lung diffusing capacity for carbon monoxide predict the presence of pulmonary hypertension?一氧化碳肺弥散量降低能否预测肺动脉高压的存在？
Am J Med Sci. 2010 Jul;340(1):54-9. doi: 10.1097/MAJ.0b013e3181dd1a89.
10
Are there sex differences in the capillary blood volume and diffusing capacity response to exercise?毛细血管血容量和弥散能力对运动的反应存在性别差异吗？
J Appl Physiol (1985). 2017 Mar 1;122(3):460-469. doi: 10.1152/japplphysiol.00389.2016. Epub 2016 Dec 8.
本文引用的文献
1
Safety, feasibility and effectiveness of the remotely delivered Pulmonary Hypertension and Home-Based (PHAHB) physical activity intervention.远程提供的肺动脉高压与居家身体活动干预（PHAHB）的安全性、可行性和有效性。
ERJ Open Res. 2024 Jan 8;10(1). doi: 10.1183/23120541.00608-2023. eCollection 2024 Jan.
2
Molecular mechanisms of exercise contributing to tissue regeneration.运动促进组织再生的分子机制。
Signal Transduct Target Ther. 2022 Nov 30;7(1):383. doi: 10.1038/s41392-022-01233-2.
3
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Heart J. 2022 Oct 11;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237.
4
COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension.COMPERA 2.0：一种改良的肺动脉高压四层风险评估模型。
Eur Respir J. 2022 Jul 7;60(1). doi: 10.1183/13993003.02311-2021. Print 2022 Jul.
5
Pulmonary hypertension and home-based (PHAHB) exercise intervention: protocol for a feasibility study.肺动脉高压和家庭（PHAHB）运动干预：一项可行性研究方案。
BMJ Open. 2021 May 10;11(5):e045460. doi: 10.1136/bmjopen-2020-045460.
6
Official ERS technical standard: Global Lung Function Initiative reference values for static lung volumes in individuals of European ancestry.ERS 官方技术标准：欧洲血统个体静态肺容量的全球肺功能倡议参考值。
Eur Respir J. 2021 Mar 11;57(3). doi: 10.1183/13993003.00289-2020. Print 2021 Mar.
7
ARTP statement on pulmonary function testing 2020.ARTP 关于肺功能测试的声明 2020.
BMJ Open Respir Res. 2020 Jul;7(1). doi: 10.1136/bmjresp-2020-000575.
8
Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies.预测肺动脉高压患者的生存情况：REVEAL 风险评分计算器 2.0 与 ESC/ERS 风险评估策略的比较。
Chest. 2019 Aug;156(2):323-337. doi: 10.1016/j.chest.2019.02.004. Epub 2019 Feb 14.
9
2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung.2017 年ERS/ATS 肺一氧化碳单次呼吸摄取量标准。
Eur Respir J. 2017 Jan 3;49(1). doi: 10.1183/13993003.00016-2016. Print 2017 Jan.
10
Low DLCO in idiopathic pulmonary arterial hypertension - clinical correlates and prognostic significance.特发性肺动脉高压患者中低一氧化碳弥散量——临床相关性及预后意义
Pneumonol Alergol Pol. 2016;84(2):87-94. doi: 10.5603/PiAP.2016.0006.
Zotero 插件